Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Evolus Inc.

    NASDAQ: EOLS · Real-Time Price · USD
    9.63
    0.25 (2.67%)
    At close: Jun 24, 2025, 3:59 PM
    9.45
    -1.84%
    After-hours: Jun 24, 2025, 07:27 PM EDT
    2.67%
    Bid 9.2
    Market Cap 620.75M
    Revenue (ttm) 275.01M
    Net Income (ttm) -56.2M
    EPS (ttm) -0.89
    PE Ratio (ttm) -10.82
    Forward PE 16.3
    Analyst Buy
    Ask 9.8
    Volume 835,165
    Avg. Volume (20D) 1,070,293
    Open 9.46
    Previous Close 9.38
    Day's Range 9.28 - 9.68
    52-Week Range 8.67 - 17.82
    Beta 0.99

    About EOLS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol EOLS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for EOLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Evolus Inc. is scheduled to release its earnings on Jul 30, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    +1.29%
    Evolus Shares Are Trading Lower After The Company ... Unlock content with Pro Subscription
    4 months ago
    +5.47%
    Evolus shares are trading higher after the company announced FDA approval of Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels.
    news image

    1 week ago · businesswire.com

    Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in June o...

    news image

    2 weeks ago · businesswire.com

    Evolysse™ Recognized in 2025 Shape Skin Awards

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, is proud to announce it has been r...

    news image

    4 weeks ago · businesswire.com

    Evolus Announces Departure of its Chief Financial Officer

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that its Chief Fin...

    news image

    1 month ago · businesswire.com

    Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced the publication of...

    news image

    1 month ago · zacks.com

    Evolus, Inc. (EOLS) Reports Q1 Loss, Misses Revenue Estimates

    Evolus, Inc. (EOLS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.13 per share a year ago.

    news image

    1 month ago · seekingalpha.com

    Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript

    Evolus, Inc. (NASDAQ:EOLS ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Nareg Sagherian - VP, Head of Global IR and Corporate Communications David Moatazedi - Presiden...

    news image

    1 month ago · businesswire.com

    Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced it has entered int...

    news image

    1 month ago · zacks.com

    Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know

    Evolus (EOLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · businesswire.com

    Evolus to Report First Quarter Financial Results on May 7, 2025

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will repor...

    news image

    2 months ago · businesswire.com

    Evolus Announces Commercial Launch of Evolysse™

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced the commercial launch date for Evolys...

    Add to Watchlist